Cohance Lifesciences : - The stock of Cohance Lifesciences surged 36.55% this week, driven by a massive fundamental catalyst: the appointment of Umang Vohra (former CEO of Cipla) as Chairman and Group CEO. Technically, the stock has undergone a "character change," breaking out from an 18-month downtrend with record-high institutional volume. MACD Histogram and signal line above zero is confirming bullish trend . The stock has crossed key short-term and medium-term averages, signaling a shift in sentiment from bearish to bullish. Oracle Financial Services Software (OFSS) surged 20.2% this week, primarily fueled by blockbuster Q4 FY26 earnings and a massive ₹270 per share second interim dividend announcement. Technically, the stock has moved into a "Strong Buy" zone. The stock is Strongly Overbought with RSI at 85.7. indicates potential for a brief consolidation or pullback. MACD Histogram and the signal line above zero is confirming strong bullish momentum. The stock is trading comfortably above all key long-term and short-term exponential moving averages.

COHANCE

OFSS

#EquityResearch#PsychologyofMoney#TechnicalViews#WatchOutFor#StockInNews

899 likes·63 comments